Australian researchers writing in The Conversation argue that people buying peptides online for muscle building, weight loss, recovery, skin or sleep are a new population of injecting drug users who do not recognize themselves in that description. Peptides are drugs, injected like any other, and they are often sold by illicit online sellers with no safety advice attached.

The authors say peptide injectors may not go looking for injecting guidance, or may assume it does not apply to them. Those who do go looking often cannot find where it lives.

The hospitalization curve

The hard number here is a steep one. Peptide-related hospitalizations in New South Wales rose from five in July 2025 to more than 200 in September 2026, according to the article.

Australia's Therapeutic Goods Administration is seeking to restrict black and gray market peptide supply. That does nothing, the authors note, for the people who already have vials in the fridge and will keep using them.

Vending machines empty by lunchtime

Needle and syringe programs, free services handing out sterile equipment, report a dramatic rise in people seeking gear for peptides. In some regional towns, syringe vending machines have emptied within hours of restocking.

These programs were historically funded to slow bloodborne viruses such as HIV. When sterile equipment runs out, the article says, people who use drugs share needles, and that is where hepatitis C and HIV transmission follow.

No leaflet, no practitioner

A vial arrives in a padded envelope, maybe with a few syringes thrown in. There is no leaflet and no health practitioner, so injectors learn from forums, influencers or someone at the gym.

That is a different world from being prescribed weight-loss injections by a primary care doctor, who demonstrates technique, supplies a sharps container and explains what an infection site looks like. The authors report reused needles, poor hygiene and missed early infection signs as the predictable result.

The vial counts as shared equipment

The five basics the authors set out include never reusing a needle, and treating vials, bacteriostatic water and swabs as shared equipment if more than one person touches them. They also note that peptides sold online are not tested like medicines, and research has found labels that do not match contents and products that are contaminated.

The remaining points cover recognizing spreading redness, heat, swelling, pus or fever, telling clinicians exactly what was injected, and disposing of sharps through a program rather than a trash can.

Budgets built for a different injector

The argument closes on funding. Services absorbing this population are working on budgets built for the number of people they served years ago, not the number arriving now.

The authors also say safety information has to reach peptide users where they already are: online, in gyms, and at the point of sale. Whether any of that gets funded is the question the piece leaves open.